Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective
The gut microbiome plays a key role in the pathogenesis of cardiovascular disease through systemic inflammation, impaired lipid metabolism, and proatherogenic gut metabolites like trimethylamine N-oxide. Gut dysbiosis contributes to decreased level of microbial metabolites such as short-chain fatty...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2026-06-01
|
| סדרה: | Biomedicines |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2227-9059/14/6/1267 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|